PortfoliosLab logoPortfoliosLab logo
apr 26 rebal 1
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Diversification

Asset Allocation


GDX 22.19%SIVR 5.51%1 position 2.15%RDIV 48.97%VOO 10.28%18 positions 7.66%1 position 3.09%AlternativesAlternativesCommodityCommodityEquityEquityMulti-AssetMulti-Asset
PositionCategory/SectorTarget Weight
ALKS
Alkermes plc
Healthcare
0.52%
CMPS
COMPASS Pathways plc
Healthcare
0.03%
DFTX
Definium Therapeutics, Inc
Healthcare
0.25%
ENVB
Enveric Biosciences Inc
Healthcare
0.07%
FMED
Fidelity Disruptive Medicine ETF
Health & Biotech Equities
0.02%
FRNW
Fidelity Clean Energy ETF
Alternative Energy Equities
0.21%
GDX
VanEck Gold Miners ETF
Gold, Precious Metals
22.19%
IBBQ
Invesco Nasdaq Biotechnology ETF
Health & Biotech Equities
0.04%
ICLN
iShares Global Clean Energy ETF
Alternative Energy Equities
0.21%
JEPQ
JPMorgan Nasdaq Equity Premium Income ETF
Nasdaq-100, Derivative Income
0.44%
MLI
Mueller Industries, Inc.
Industrials
0.88%
MRNY
YieldMax MRNA Option Income Strategy ETF
Derivative Income, Dividend, Actively Managed
0.15%
MSTY
YieldMax™ MSTR Option Income Strategy ETF
Derivative Income
0.15%
OUNZ
VanEck Merk Gold Trust
Precious Metals, Gold
2.15%
PBD
Invesco Global Clean Energy ETF
Alternative Energy Equities
0.22%
PBE
Invesco Dynamic Biotechnology & Genome ETF
Health & Biotech Equities
0.48%
PPH
VanEck Vectors Pharmaceutical ETF
Health & Biotech Equities
2.54%
PSIL
AdvisorShares Psychedelics ETF
Health & Biotech Equities
0.13%
RAAX
VanEck Inflation Allocation ETF
Diversified Portfolio, Actively Managed
3.09%
RDIV
Invesco S&P Ultra Dividend Revenue ETF
Mid Cap Value Equities, Dividend
48.97%
SCHG
Schwab U.S. Large-Cap Growth ETF
Large Cap Growth Equities
0.73%
SIVR
Aberdeen Standard Physical Silver Shares ETF
Precious Metals
5.51%
VOO
Vanguard S&P 500 ETF
S&P 500
10.28%
VXUS
Vanguard Total International Stock ETF
Global Equities
0.73%
VYGR
Voyager Therapeutics, Inc.
Healthcare
0.01%

S&P 500 Index

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in apr 26 rebal 1, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends. The portfolio is rebalanced Every 3 months.


Loading graphics...

The earliest data available for this chart is Feb 22, 2024, corresponding to the inception date of MSTY

Returns By Period


1D1MYTD6M1Y3Y*5Y*10Y*
Benchmark
S&P 500 Index
-0.11%2.16%-0.42%4.03%27.10%18.38%10.55%12.70%
Portfolio
apr 26 rebal 1
-0.07%0.74%8.54%19.12%52.35%
ALKS
Alkermes plc
-4.47%20.69%19.23%6.89%23.56%4.97%11.89%-1.31%
CMPS
COMPASS Pathways plc
-0.90%-16.59%-19.86%-11.09%94.04%-18.83%-31.17%
DFTX
Definium Therapeutics, Inc
0.51%19.74%60.79%82.30%296.50%92.68%
ENVB
Enveric Biosciences Inc
-3.77%2.24%-45.92%-73.83%-86.91%-79.83%-84.91%-74.32%
MLI
Mueller Industries, Inc.
0.24%9.66%5.87%25.63%65.30%53.99%42.59%26.04%
VYGR
Voyager Therapeutics, Inc.
-5.56%-23.20%-4.83%-25.20%17.98%-22.32%-4.71%-10.21%
FMED
Fidelity Disruptive Medicine ETF
-1.31%1.85%-8.21%-2.51%9.19%
FRNW
Fidelity Clean Energy ETF
0.97%5.54%17.75%18.17%93.57%3.95%
GDX
VanEck Gold Miners ETF
1.06%0.09%15.88%32.11%101.43%43.86%25.13%16.96%
IBBQ
Invesco Nasdaq Biotechnology ETF
-1.62%1.81%2.50%15.80%50.57%12.66%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Monthly Returns

Based on dividend-adjusted daily data since Feb 23, 2024, apr 26 rebal 1's average daily return is +0.13%, while the average monthly return is +2.56%. At this rate, an investment would double in approximately 2.3 years.

Historically, 78% of months were positive and 22% were negative. The best month was Aug 2025 with a return of +10.0%, while the worst month was Mar 2026 at -7.6%. The longest winning streak lasted 5 consecutive months, and the longest losing streak was 1 months.

On a daily basis, apr 26 rebal 1 closed higher 60% of trading days. The best single day was Apr 9, 2025 with a return of +7.1%, while the worst single day was Apr 4, 2025 at -6.1%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20266.60%8.00%-7.56%1.99%8.54%
20255.76%1.53%2.55%-1.96%3.14%3.26%0.80%9.99%7.75%-0.59%6.02%2.14%47.85%
20240.72%9.14%-1.44%5.98%-1.90%7.33%2.45%1.85%0.54%1.82%-6.71%20.48%

Benchmark Metrics

apr 26 rebal 1 has an annualized alpha of 24.74%, beta of 0.69, and R² of 0.43 versus S&P 500 Index. Calculated based on daily prices since February 23, 2024.

  • This portfolio captured 145.17% of S&P 500 Index gains but only 19.64% of its losses — a favorable profile for investors.
  • Beta of 0.69 may look defensive, but with R² of 0.43 this portfolio is largely uncorrelated with S&P 500 Index — low beta reflects independence, not downside protection. See the Volatility section for a true picture of this portfolio's risk.
  • R² of 0.43 means the benchmark explains less than half of this portfolio's behavior — treat beta with caution or consider switching to a more representative benchmark.

Alpha
24.74%
Beta
0.69
0.43
Upside Capture
145.17%
Downside Capture
19.64%

Expense Ratio

apr 26 rebal 1 has an expense ratio of 0.38%, placing it in the medium range. Below, you can find the expense ratios of the portfolio's funds side by side and easily compare their relative costs.


Top 10 holdings

Return for Risk

Risk / Return Rank

apr 26 rebal 1 ranks 80 for risk / return — better than 80% of portfolios on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.


apr 26 rebal 1 Risk / Return Rank: 8080
Overall Rank
apr 26 rebal 1 Sharpe Ratio Rank: 8888
Sharpe Ratio Rank
apr 26 rebal 1 Sortino Ratio Rank: 7070
Sortino Ratio Rank
apr 26 rebal 1 Omega Ratio Rank: 8484
Omega Ratio Rank
apr 26 rebal 1 Calmar Ratio Rank: 7878
Calmar Ratio Rank
apr 26 rebal 1 Martin Ratio Rank: 8080
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics


PortfolioBenchmarkDifference

Sharpe ratio

Return per unit of total volatility

3.32

2.23

+1.08

Sortino ratio

Return per unit of downside risk

3.90

3.12

+0.78

Omega ratio

Gain probability vs. loss probability

1.59

1.42

+0.17

Calmar ratio

Return relative to maximum drawdown

5.23

4.05

+1.19

Martin ratio

Return relative to average drawdown

21.62

17.91

+3.71


How much return does each position deliver for the risk it carries? Higher values mean better reward for the risk taken.

Risk / Return RankSharpe ratioSortino ratioOmega ratioCalmar ratioMartin ratio
ALKS
Alkermes plc
480.651.201.150.831.73
CMPS
COMPASS Pathways plc
671.151.841.292.116.56
DFTX
Definium Therapeutics, Inc
965.174.501.5413.7342.06
ENVB
Enveric Biosciences Inc
6-0.65-1.280.83-0.95-1.50
MLI
Mueller Industries, Inc.
832.572.991.443.5310.13
VYGR
Voyager Therapeutics, Inc.
450.371.071.120.841.72
FMED
Fidelity Disruptive Medicine ETF
140.641.061.120.872.56
FRNW
Fidelity Clean Energy ETF
924.014.581.599.4429.24
GDX
VanEck Gold Miners ETF
602.552.691.394.5815.86
IBBQ
Invesco Nasdaq Biotechnology ETF
762.633.461.436.6622.15

Sharpe Ratio

The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk.

apr 26 rebal 1 Sharpe ratios as of Apr 11, 2026 (values are recalculated daily):

  • 1-Year: 3.32
  • All Time: 2.14

These values reflect how efficiently the investment has delivered returns relative to its volatility over different time periods. All figures are annualized and based on daily total returns (including price changes and dividends).

Compared to the broad market, where average Sharpe ratios range from 2.14 to 3.05, this portfolio's current Sharpe ratio is in the top 25%. This signifies superior risk-adjusted performance, meaning the portfolio is delivering strong returns for the level of risk taken compared to most others.

The chart below shows the rolling Sharpe ratio of apr 26 rebal 1 compared to the selected benchmark. This view highlights how the investment's risk-adjusted performance has changed over time.


Loading graphics...

Dividends

Dividend yield

apr 26 rebal 1 provided a 2.91% dividend yield over the last twelve months.


TTM20252024202320222021202020192018201720162015
Portfolio2.91%3.10%3.01%2.69%2.41%2.47%2.96%2.39%2.56%2.61%1.46%2.70%
ALKS
Alkermes plc
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
CMPS
COMPASS Pathways plc
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
DFTX
Definium Therapeutics, Inc
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
ENVB
Enveric Biosciences Inc
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
MLI
Mueller Industries, Inc.
0.91%0.87%1.01%1.27%1.69%0.88%1.14%1.26%1.71%9.60%0.94%1.11%
VYGR
Voyager Therapeutics, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
FMED
Fidelity Disruptive Medicine ETF
0.00%0.00%0.46%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
FRNW
Fidelity Clean Energy ETF
1.07%1.25%1.43%1.30%0.69%0.04%0.00%0.00%0.00%0.00%0.00%0.00%
GDX
VanEck Gold Miners ETF
0.64%0.74%1.19%1.61%1.66%1.67%0.53%0.67%0.50%0.76%0.26%0.85%
IBBQ
Invesco Nasdaq Biotechnology ETF
0.86%0.90%1.14%0.81%0.76%0.63%0.00%0.00%0.00%0.00%0.00%0.00%

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading graphics...

Worst Drawdowns

The table below displays the maximum drawdowns of the apr 26 rebal 1. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the apr 26 rebal 1 was 12.44%, occurring on Mar 20, 2026. The portfolio has not yet recovered.

The current apr 26 rebal 1 drawdown is 5.76%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-12.44%Mar 3, 202614Mar 20, 2026
-11.95%Apr 3, 20254Apr 8, 202528May 19, 202532
-8.67%Oct 23, 202441Dec 19, 202436Feb 13, 202577
-6.37%Jul 17, 202416Aug 7, 20248Aug 19, 202424
-6.29%Jan 29, 20266Feb 5, 202613Feb 25, 202619

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading graphics...

Diversification

Diversification Metrics


Number of Effective Assets

The portfolio contains 25 assets, with an effective number of assets of 3.28, reflecting the diversification based on asset allocation. This number of effective assets suggests a highly concentrated portfolio, where a few assets dominate the allocation, potentially increasing the portfolio's risk due to lack of diversification.

Asset Correlations Table

The table below displays the correlation coefficients between the individual components of the portfolio, the entire portfolio, and the chosen benchmark.

BenchmarkENVBOUNZALKSSIVRMSTYDFTXGDXCMPSPPHMRNYVYGRPSILMLIRDIVRAAXICLNFRNWSCHGJEPQPBEFMEDPBDIBBQVOOVXUSPortfolio
Benchmark1.000.220.110.280.220.430.340.240.340.370.370.400.400.560.500.380.480.530.940.940.550.640.610.551.000.720.54
ENVB0.221.000.020.140.080.130.190.080.140.160.240.220.280.190.220.130.170.210.180.180.250.300.220.250.220.190.22
OUNZ0.110.021.000.020.750.120.070.790.090.120.120.100.110.080.040.660.230.210.080.110.130.120.230.160.110.350.64
ALKS0.280.140.021.000.050.160.200.070.200.350.300.350.200.280.330.140.210.220.200.200.500.400.270.500.280.260.26
SIVR0.220.080.750.051.000.190.110.760.160.110.180.110.140.110.090.550.280.280.200.230.170.170.340.200.230.440.68
MSTY0.430.130.120.160.191.000.300.180.270.060.220.300.300.290.240.240.300.360.460.440.290.330.420.300.440.360.30
DFTX0.340.190.070.200.110.301.000.110.480.180.220.380.590.260.220.230.260.280.330.320.390.370.290.440.340.300.25
GDX0.240.080.790.070.760.180.111.000.120.180.160.120.140.170.120.610.340.330.200.230.210.220.340.240.250.470.80
CMPS0.340.140.090.200.160.270.480.121.000.200.310.430.570.190.220.180.250.300.330.310.390.420.350.490.340.330.25
PPH0.370.160.120.350.110.060.180.180.201.000.350.300.230.260.400.200.240.250.220.240.610.530.280.650.370.450.41
MRNY0.370.240.120.300.180.220.220.160.310.351.000.400.280.310.330.220.330.350.300.320.500.490.440.580.370.410.35
VYGR0.400.220.100.350.110.300.380.120.430.300.401.000.370.300.320.170.250.310.350.340.490.480.360.570.390.370.31
PSIL0.400.280.110.200.140.300.590.140.570.230.280.371.000.250.240.280.280.330.390.380.420.460.370.480.410.340.29
MLI0.560.190.080.280.110.290.260.170.190.260.310.300.251.000.550.370.310.370.440.460.440.440.430.390.550.470.47
RDIV0.500.220.040.330.090.240.220.120.220.400.330.320.240.551.000.410.340.390.270.320.500.440.440.480.500.480.62
RAAX0.380.130.660.140.550.240.230.610.180.200.220.170.280.370.411.000.390.410.260.320.280.270.430.300.380.510.74
ICLN0.480.170.230.210.280.300.260.340.250.240.330.250.280.310.340.391.000.930.410.450.370.370.810.420.480.630.48
FRNW0.530.210.210.220.280.360.280.330.300.250.350.310.330.370.390.410.931.000.470.500.390.430.880.430.530.660.50
SCHG0.940.180.080.200.200.460.330.200.330.220.300.350.390.440.270.260.410.471.000.950.450.580.550.460.940.630.39
JEPQ0.940.180.110.200.230.440.320.230.310.240.320.340.380.460.320.320.450.500.951.000.460.570.600.470.930.680.44
PBE0.550.250.130.500.170.290.390.210.390.610.500.490.420.440.500.280.370.390.450.461.000.750.460.880.550.520.49
FMED0.640.300.120.400.170.330.370.220.420.530.490.480.460.440.440.270.370.430.580.570.751.000.500.780.640.570.46
PBD0.610.220.230.270.340.420.290.340.350.280.440.360.370.430.440.430.810.880.550.600.460.501.000.510.620.770.55
IBBQ0.550.250.160.500.200.300.440.240.490.650.580.570.480.390.480.300.420.430.460.470.880.780.511.000.560.540.50
VOO1.000.220.110.280.230.440.340.250.340.370.370.390.410.550.500.380.480.530.940.930.550.640.620.561.000.730.54
VXUS0.720.190.350.260.440.360.300.470.330.450.410.370.340.470.480.510.630.660.630.680.520.570.770.540.731.000.68
Portfolio0.540.220.640.260.680.300.250.800.250.410.350.310.290.470.620.740.480.500.390.440.490.460.550.500.540.681.00
The correlation results are calculated based on daily price changes starting from Feb 23, 2024